Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

i3 Health

Optimizing the Clinical Outcomes of Patients With Immune Thrombocytopenia

Access Activity

Overview / Abstract:


Immune thrombocytopenia (ITP) is a heterogeneous disorder with variable clinical features that range from asymptomatic thrombocytopenia to bothersome bruising to life-threatening intracranial hemorrhage. The lack of specific diagnostic criteria remains an important unmet need. Bleeding events are the most common clinical manifestation of ITP but are unpredictable with current laboratory testing. Many patients do not exhibit significant bleeding even in the setting of severe thrombocytopenia. While bleeding is an indication for treatment, clinical management is often influenced by other considerations, including tolerability of therapy, comorbidities with a predisposition to bleeding, the need for interventions that may cause bleeding, complications of specific therapies, accessibility of care, and patient factors (eg, worry or anxiety about disease burden, activity level, lifestyle). For this reason, the goals of therapy and/or efficacy measures of treatment response can vary significantly between patients.


Hematology/oncology physicians, oncology advanced practitioners, oncology nurses, and other health care professionals involved in the treatment of patients with ITP.


Upon completion of this activity, participants should be able to:

1. Discuss the pathogenesis of ITP and mechanisms of therapeutic strategies
2. Differentiate the efficacy and safety profiles of current and emerging ITP therapies
3. Assess supportive care strategies that can be used to help patients with ITP achieve their goals of therapy


Nov 05, 2020


Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME


Monograph, Online

Credits / Hours




Presenters / Authors / Faculty

James B. Bussel, MD (Chairperson)
Professor of Pediatrics
Weill Cornell Medicine

Allison Miller Imahiyerobo, APN
Advanced Practice Nurse
Hematology and Oncology Physicians of Englewood

Sponsors / Supporters / Grant Providers

This activity is supported by an independent educational grant from Amgen.

Keywords / Search Terms

i3 Health i3 Health, immune thrombocytopenia, hematologic malignancies, hematology, hematology/oncology, ITP, CME, CNE, free CME, free CNE Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.